SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 18, 2026

WGS

GeneDx Holdings Corp.
BEARISH
Impact 4/10
Horizonweeks Processed1mo ago
Insider cluster: 2 insiders, $366K total
Actionable Insight ▼ Bearish

CEO open-market selling without a disclosed 10b5-1 plan is a modest negative signal. Monitor for additional insider sales or a Form 144 filing that would indicate a larger planned distribution. The stock's recent sharp moves (prior cluster buys were highly profitable) make this sale worth tracking for a potential shift in insider sentiment.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+20d
WGS ▼ -32.24% at T+20d
SHORT call ✓ call won +32.24% · α vs SPY +31.33% · entry $97.83 → $66.29
Next anchor: T+60d in 7w
Latest observation: T+24 +51.76% FF3 residual α
Entry = T+0 close
Sep 18, 2026
via day close
T+1d
-7.19%
call +7.19% · α +7.17%
$90.80
settled 5w ago
T+5d
-12.16%
call +12.16% · α +11.14%
$85.93
settled 5w ago
T+20d
-32.24%
call +32.24% · α +31.33%
$66.29
settled 11d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

GeneDx CEO Katherine Stueland and CFO Kevin Feeley sold a combined $366K in open-market sales over a one-week window. The CEO sale ($311K) is the dominant transaction; the CFO sale ($55K) is routine in size. The cluster is small relative to market cap and lacks a clear catalyst, but the CEO's sale warrants attention given the stock's recent volatility.

Key Financial Metrics

Direction
selling
Total Value
$366.0K
Insiders
2

Key Facts

  • CEO Katherine Stueland sold 3,700 shares at $84.22 for $311K on 2026-09-09.
  • CFO Kevin Feeley sold 586 shares at $94.26 for $55K on 2026-09-16.
  • Total cluster value of $366K is all open-market sales (code S).
  • No 10b5-1 plan indication provided for either sale.
  • Director Thomas Fuchs exercised non-cash derivatives (code M) on 2026-09-17 — no economic signal.

Financial Impact

$366K in insider sales, all open-market; no material percentage of market cap disclosed.

insider ownershipfloat

Risk Factors

  • CEO sale may be liquidity-driven (e.g., tax planning, diversification) rather than informational.
  • Small absolute dollar amount limits signal strength.
  • No guidance or earnings event in the window to contextualize the sale.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-WGS-1789763979371
10 reports for WGS
Performance horizon
100% Hit rate @ T+60 5 of 5 directional calls Went positive at some point 5 of 5 best @ T+60▲ +63.51%May 20, 2026
Filters
Rows
Reports for WGS — sortable, filterable
TypeNow
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$97.83awaiting T+60—$65.40 (+33.15%)
Sep 11, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$89.74awaiting T+60—$65.40 (−27.12%)
Sep 1, 2026
7w ago
144
NEUTRAL ★ 2/10
$86.72awaiting T+60—$65.40 (−24.58%)
Jun 16, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$60.60 $83.96▲ +38.55%▲ +37.55%$65.40 (+7.92%)
Jun 11, 2026
19w ago
Institutional Cluster
BULLISH ★ 4/10
$59.92 $85.87▲ +43.31%▲ +40.04%$65.40 (+9.15%)
Jun 8, 2026
20w ago
Insider Cluster
BULLISH ★ 6/10
$56.33 $86.72▲ +53.95%▲ +50.14%$65.40 (+16.10%)
May 20, 2026
22w ago
Insider Cluster
BULLISH ★ 6/10
$47.33 $77.39▲ +63.51%▲ +59.21%$65.40 (+38.18%)
Mar 26, 2026
30w ago
Insider Cluster
BEARISH ★ 6/10
$61.35 $56.93▲ +7.21%▲ +21.16%$65.40 (−6.60%)
Mar 4, 2026
33w ago
Insider Cluster
BEARISH ★ 6/10
$79.47 $50.15▲ +36.89%▲ +46.98%$65.40 (+17.70%)
Mar 4, 2026
33w ago
Insider Cluster
NEUTRAL ★ 4/10
$79.47 $50.15▼ −36.89%▼ −46.98%$65.40 (−17.70%)
Showing 10 of 10

US Market Status

Market Open — Closes in 5h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 18, 2026